资讯

Targeted Oncology12 小时
Optimizing Treatment Selection and Sequencing in Metastatic Melanoma
During a live event, Ahmad Tarhini, MD, PhD, and participants discussed how to use combination immunotherapy in patients with ...
Targeted Oncology14 小时
FDA OKs Perioperative Pembrolizumab in HNSCC: Findings From KEYNOTE-689
Ravindra Uppaluri, MD, PhD, discusses findings from the KEYNOTE-689 trial in adult patients with resectable, locally advanced head and neck squamous cell carcinoma.